Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia-Reference-Cited by-同舟云学术

Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia

Published:2010-05 Issue:9 Volume:20 Page:2983-2986
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Yan Yinfa,Zhou Ping,Rotella David P.,Feenstra Rolf,Kruse Chris G.,Reinders Jan-Hendrik,Neut Martina van der,Lai Margaret,Zhang Jean,Kowal Dianne M.,Carrick Tikva,Marquis Karen L.,Pausch Mark H.,Robichaud Albert J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference12 articles.

1. Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

2. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression—lack of manic induction

3. Olanzapine/Fluoxetine Combination for the Treatment of Mixed Depression in Bipolar I Disorder

4. Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia

5. A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accessing 3,4-Dihydroquinolinone from N-Arylacrylamides via Tetralone-Mediated Energy Transfer and 1,3-Hydrogen Shift;Organic Letters;2024-03-18

2. Generation of Thioxanthone Hydrogen Anion by Double Photoreduction and Uses for Catalytic Photoreductions;ACS Catalysis;2023-10-09

3. Indirect electrochemical reductive cyclization ofo-halophenylacrylamides mediated by phenanthrene;Organic Chemistry Frontiers;2023

4. Divergent synthesis of nitrogen heterocyclesviaH₂O-mediated hydride transfer reactions;Green Chemistry;2023

5. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16